Research
Open Access

Body shape index versus body mass index as correlates of health risk in young healthy sedentary men

  • Marzena Malara1,
  • Anna Kęska1,
  • Joanna Tkaczyk1 and
  • Grażyna Lutosławska1Email author
Journal of Translational Medicine201513:75

https://doi.org/10.1186/s12967-015-0426-z

©  Malara et al.; licensee BioMed Central. 2015

Received: 18 September 2014

Accepted: 2 February 2015

Published: 27 February 2015

Abstract

Recently a new simply calculated index of body composition -a body shape index (ABSI) has been introduced as an index more reliable than BMI of association between body composition and all-cause mortality. However, until now associations between ABSI and metabolic risk factors have not been evaluated. A total of 114 male university students not engaged in any planned physical activity participated in the present study. Anthropometric measurements (weight, height, waist circumference) were recorded. Body mass index (BMI) was calculated from weight and height, body shape index (ABSI) was calculated from waist circumference, weight, height and BMI. Blood was withdrawn after an overnight fast from the antecubital vein. Triacylglycerols, total cholesterol and HDL-cholesterol levels in plasma were determined using colorimetric methods and Randox commercial kits. Plasma LDL-cholesterol concentrations were calculated according to the Friedewald formula. Circulating insulin was assayed using a standard radioimmunological method with monoclonal antibodies against insulin and BioSource commercial kits. BMI was slightly, but significantly correlated only with circulating TG (r=0.330, p < 0.001) In contrast, ABSI was slightly, but significantly correlated with plasma levels of insulin (r=0.360, p<0.001), TC (r=0.270, p<0.002), LDL-C and non-HDL-C (r=0.300, p<0.001). In participants at the upper quartile of BMI circulating TG was higher (by 50%, p<0.05) than in their counterparts at the lower BMI quartile. Subjects representing the upper quartile of ABSI were characterized by higher plasma levels of insulin, TC, LDL-C and non-HDL in comparison with subjects at the lower ABSI quartile. (by 92 %, 11. %, 29 % and 21 % respectively, p<0.001). ABSI, a new simply calculated index of body fat seems to more accurately depict the variability in circulating insulin and lipoproteins than BMI at least in young, healthy male subjects.

Keywords

Body mass index Body shape index Insulin Lipoproteins

Background

At present obesity is recognized as the main cause of type 2 diabetes, cardiovascular disease and an important contributing factor in some cancers [1]. In consequence, precise obesity criteria and diagnosis are of special importance in medical practice.

There is a wide range of methods for body fat determination, which are suitable in laboratory practice (BIA, DEXA, CT, and MRI); however, they require costly equipment, which is not always available [2-4]. Much simpler skinfold measurement are time-consuming and have to be performed by experienced technicians [5]. Thus, they are not suitable either for everyday medical practice or in population-based studies. According to WHO recommendations, the body mass index (BMI) calculated from body weight and height and waist circumference (WC) are a valid indicators of fatness and this assumption has been supported by many studies concerning their associations with health risk [6-8]. On the other hand, there are data questioning BMI reliability and indicating that it provides a false diagnosis of body fatness [9,10]. There are also data indicating that regional fat distribution, but not total body fat stores, are related to metabolic disturbances and health risks [11,12]. Furthermore, it has been demonstrated that WHO standards of BMI are not suitable for the evaluation of body fat with respect to ethnicity [13].

Similarly, many doubts exist with respect to associations between BMI and mortality. Assuming that BMI provides reliable information concerning body fatness and taking into account detrimental effects of fat excess on health and mortality, it is not clear why the BMI-mortality relationship is U-shaped, suggesting high mortality in both lean and obese humans [14-16]. Moreover, it is worth noting that in young healthy adults BMI, but also other surrogate indices of fatness (e.g. waist-to-height ratio, body adiposity index) provide poor prognosis of fat mass since they reflect mostly skeletal muscle mass [17,18].

In the literature there are many other simple surrogate indices of body fat such as the waist-to-height ratio (e.g. weight-to-height ratio-WtHR), conicity index - CI, body adiposity index -BAI), however, their validity in respect to BMI is still under debate [19-22]. Recently Krakauer and Krakauer [23] proposed a new simply calculated index of body composition (a body shape index - ABSI) as more reliable than BMI in determination of association between all-cause mortality and body composition. However, data concerning relationship of ABSI with health risk are controversial. ABSI was found to predict resting blood pressure in adolescents more precisely than BMI [24]. On the contrary, ABSI predictive ability was not better than BMI with respect to type 2 diabetes, hypertension and cardiovascular disease in Chinese and Iranian populations [25-27]. The reason for this discrepancy is unknown, however, it may be due to ethnic differences in body fat distribution [28]. In addition, it cannot be excluded that BMI reflecting mostly total body fat differs in its relationship to metabolic variables from ABSI, which encompasses waist circumference, thus at least partially depicts fat distribution [29].

Thus, this study was undertaken and aimed at the evaluation of the relationship between ABSI and BMI and biochemical variables contributing to health risk in sedentary young male adults.

Methods

Participants

We studied a sample of 114 male university students recruited through word-of-mouth, and posters displayed at the university and in student dormitories. They were selected from 148 volunteers because they agreed to venous blood withdrawal under fasting conditions. All participants were healthy non-smokers not engaged in planned physical activity and not taking any medication on a regular basis. They were informed about procedures and all provided their written consent. The study protocol was accepted by the local ethics committee at the Jósef Piłsudski University of Physical Education.

Anthropometric measurements

Body mass was measured to the nearest 0.1 kg and body height to the nearest 0.5 cm using standard medical equipment in subjects wearing light indoor clothing without shoes, jackets and sweaters. Body mass index (BMI) was calculated as body mass (kg) divided by height (m) squared. The subjects’ adiposity was classified according to WHO standards: underweight was defined as BMI < 18.5, normal weight as BMI ≥ 18.5 and <25, overweight as BMI ≥ 25 to BMI <30, and obesity as a BMI ≥30 [30]. Waist circumference (WC) was measured in the midway section between the lower edge of the ribs and the iliac crest with an accuracy of 0.1 cm using non-stretchable tape and values <102 cm were accepted as normal [30]. All measurements were performed twice but in case of divergent results were repeated for the third time. A Body Shape Index (ABSI) was calculated according to Krakauer and Krakauer [23] and the following formula:
$$ \mathrm{ABSI} = \mathrm{W}\mathrm{C}\left(\mathrm{m}\right)/\left[{\mathrm{BMI}}^{2/3} \times \mathrm{height}\ {\left(\mathrm{m}\right)}^{1/2}\right] $$

Blood tests

Participants were asked to refrain from physical activity for 48 h before blood sampling. They were tested in the morning (8:00–8:30 a.m.) after an overnight fast. Venous blood was collected under aseptic conditions into plastic tubes containing anticoagulant and centrifuged at 4°C. Plasma was stored at -70° until analysis.

Glucose was determined using the GOD-PAP method. Circulating glucose was classified according to the International Diabetes Federation with 5.5 mmol/l accepted as the upper level [31]. Triacylglycerols (TG), total cholesterol (TC), and HDL-cholesterol (HDL-C) were assayed colorimetrically. All variables were determined using commercial kits (Randox Laboratories, Great Britain). Coefficients of variation for these analyses did not exceed 5%. The plasma level of LDL-cholesterol (LDL-C) was calculated according to the Friedewald equation [32]. Non-HDL-cholesterol (non-HDL-C) was calculated by subtraction of HDL-C from TC [33]. Concentrations of plasma lipoproteins were classified according to recommendations of the European Atherosclerosis Society and European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (TG <1.7 mmol/l, TC < 4.5 mmol/l, HLD-C >1.0 mmol/l, LDL-C < 2.5 mmol/l, non-HDL < 2.5 mmol/l [34,35]. Plasma insulin was assayed using a standard radioimmunoassay with monoclonal antibodies against insulin and commercial kits (BioSource, Belgium). The sensitivity of the method was 1 μIU/ml, intra and inter-assay coefficients of variation were 6.8% and 9.3%, respectively. All analyses were run in duplicate.

Statistical analyses

Data are presented as mean ± SD. All variables were checked for normality using the Shapiro-Wilk test. The Pearson correlation coefficients were calculated for logarithmically (e-based) transformed data. Moreover, biochemical variables were interpreted with respect to lower and upper quartile of BMI and ABSI and the Mann–Whitney test was used for data comparison. A p value ≤ 0.05 was considered to be statistically significant. All calculations were carried out using the Statistica v.7 (Statsoft, Illinois, USA).

Results

Baseline characteristics of the participants are presented in Table 1. According to BMI standards 74.6% of participants were normal weight, 18.4% were overweight, and 7.0% were obese. Only 2.0% of our subjects were characterized by higher than recommended waist circumference. Circulating glucose and triacylglycerols were higher than normal in similar percentages of students (6.1%). Slightly more participants (8.8%) were characterized by lower than normal HDL-cholesterol. On the contrary, higher than normal TC, LDL-C and non-HDL-C were observed in 24.5%, 25.4% and 29.8% of participants, respectively.
Table 1

Anthropometric characteristics and biochemical variables in young healthy men (means ± SD)

Variable

n = 114

Age (years)

21.7 ± 1.4

Weight (kg)

77.2 ± 12.2

Height (cm)

180.3 ± 6.7

BMI

23.7 ± 3.3 (25.4)*

Waist (cm)

80.7 ± 8.9 (2.0)*

ABSI

0.073 ± 0.003

Glucose (mmol/l)

4.8 ± 0.5 (6.1)^

Insulin (μIU/ml)

10.5 ± 6.4

TG (mmol/l)

0.9 ± 0.4 (6.1)^

TC (mmol/l)

4.5 ± 0.8 (24.5)^

HDL-C (mmol/l)

1.4 ± 0.3 (8.8)^

LDL-C (mmol/l)

2.7 ± 0.7 (25.4)^

Non-HDL (mmol/l)

3.1 ± 0.8 (29.8)^

BMI – body mass index; ABSI- a body shape index; TG-triacylglycerols; TC-total cholesterol; HDL-C- HDL- cholesterol; LDL-C – LDL-cholesterol;* percent of participants with overweight and obesity; ^percent of participants with disturbed biochemical variables.

BMI was slightly, but significantly correlated only with circulating TG (r = 0.330, p < 0.001). On the contrary, ABSI was slightly, but significantly correlated with plasma levels of insulin (r = 0.360, p < 0.001), TC (r = 0.270, p < 0.002), LDL-C and non-HDL-C (r = 0.300, p < 0.001) (data not shown).

In participants at the upper BMI quartile circulating TG was higher (by 50%, p < 0.05) than in their counterparts at the lower BMI quartile (Table 2). Subjects representing the upper quartile of ABSI were characterized by higher plasma levels of insulin, TC, LDL-C and non-HDL (by 92%, 11. %, 29% and 21%, respectively, p < 0.001) in comparison with subjects at the lower ABSI quartile.
Table 2

Biochemical variables in young healthy men according to lower and upper quartiles of BMI and ABSI

Variable

Glucose

Insulin

TG

TC

HDL-C

LDL-C

Non-HDL

BMI

Q1 (20.0 ± 0.9)

4.8 ± 0.6

10.4 ± 7.2

0.8 ± 0.4

4.5 ± 0.9

1.4 ± 0.3

2.7 ± 0.8

3.0 ± 08

Q 4 (28.2 ± 2.8)

5.1 ± 0.4

10.5 ± 4.8

1.2 ± 0.5a

4.5 ± 0.8

1.3 ± 0.3

2.7 ± 0.8

3.2 ± 0.8

ABSI

Q1 (0.069 ± 0.001)

4.9 ± 0.5

7.2 ± 2.9

0.9 ± 0.4

4.3 ± 0.8

1.4 ± 0.2

2.4 ± 0.8

2.9 ± 0.8

Q 4 (0.077 ± 0.002)

4.9 ± 0.5

13.8 ± 7.6b

0.9 ± 0.4

4.8 ± 0.9

1.3 ± 0.3

3.1 ± 0.8b

3.5 ± 0.8b

For abbreviations see Table 1; Q1 , Q4 - lower and upper quartile, respectively; aP < 0.05; bP <0.001.

Discussion

The most important finding of our study concerns ABSI, which is better correlated to changes in circulating TC and insulin than BMI in young sedentary men. It is worth noting that the homogeneity of our participants according to age and sex strengthens our findings. Additionally, taking into account that disturbances in biochemical parameters (insulin, glucose, and lipoproteins) bring about health deteriorations, it could be tentatively postulated that ABSI may be of importance in risk prognosis of type 2 diabetes and/or atherogenesis [36]. On the other hand, it should be stressed that ABSI validity in the prognosis of cardiovascular disease (CVD) is far from being elucidated since Maessen et al. [37] have not found ABSI capable of determining the presence of this disease in middle-aged subjects.

It should be stressed that in some way ABSI agrees with the WHO recommendation concerning waist circumference inclusion into health risk evaluation [30]. Similarly, other authors have suggested that both BMI and WC contribute to the prediction of body adiposity in white men and women [38]. The importance of WC measurements in diagnosis of health risk has been suggested by many authors since it has been postulated that WC provides indirect information about visceral fat accumulation [39,40]. At present it is well documented that visceral fat due to its location and metabolic characteristics contributes to distorted metabolism to a much greater extent than subcutaneous fat [41,42].

However, it is worth noting that mathematical correlations between metabolic variables and surrogate indices of fatness found in our study do not mean a direct cause-effect relationship. On the other hand, marked differences in metabolic profiles of subjects selected according to lower and upper quartiles of ABSI may suggest that ABSI, but not BMI, depicts variability in circulating insulin and lipoproteins in participants of our study mostly characterized by normal body fat according to BMI standards. Thus, it seems feasible that ABSI allows diagnosis of slight metabolic disturbances observed in otherwise healthy subjects [43,44]. In addition, assuming that lower and upper quartiles of BMI varied by 41% (28.2 versus 20.0) and ABSI quartiles differ by 11.6% (0.077 versus 0.069) it seems that even minor changes in ABSI provide information about variability in metabolic risk.

However, more studies are needed to prove this hypothesis, because of limitations of our study: the low number of participants from one social group, living in a big city, and representing one sex and one ethnicity.

Conclusions

Our study evaluated relationships between two surrogate measures of body composition – body mass index (BMI) and a body shape index (ABSI) with blood biochemical variables which contribute to health risk (glucose and lipoproteins).

Participants classified according to lower and upper quartile of ABSI markedly differ with respect to circulating insulin, total cholesterol, LDL-cholesterol and non-HDL-cholesterol. On the contrary, participants classified according to lower and upper quartile of BMI slightly differ exclusively with respect to circulating triacylglycerols.

Thus, in young and otherwise healthy sedentary men ABSI is a better predictor than BMI of variability in biochemical parameters, which may indicate disturbed metabolic processes.

Declarations

Acknowledgements

We would like to thank all the students who volunteered for the study.

Authors’ Affiliations

(1)
Department of Biochemistry and Biology, Józef Pilsudski University of Physical Education

References

  1. Camici M, Galetta F, Capri A: Obesity and increased risk for atherosclerosis and cancer. Int Med 2014, http://dx.doi.org/10.4172/2165-8048.1000154Google Scholar
  2. Sun G, French CR, Martin GR, Younghusband B, Green RC, Xie Y, et al. Comparison of multifrequency bioelectrical impedance analysis with dual-X-ray absorptiometry for assessment of percentage body fat in a large, healthy population. Am J Clin Nutr. 2005;81:74–8.PubMedGoogle Scholar
  3. Camhi SM, Bray GA, Bouchard C, Greenway FI, Johnson WD, Newton RL, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity. 2011;19:402–8.View ArticlePubMed CentralPubMedGoogle Scholar
  4. Neamat-Allah J, Wald D, Hüsing A, Teucher B, Wendt A, Delorme S, et al. Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging – a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) Cohorts. PLoS ONE. 2014;9:e91586.View ArticlePubMed CentralPubMedGoogle Scholar
  5. Anthropometry procedure manual. www.cdc.gov/nchs/data/nhanes/nhanes_07_08/mnual_an.pfd
  6. Feller S, Boeing H, Pischon T. Body mass index, waist circumference, and the risk of type 2 diabetes mellitus. Dtsch Arztebl Int. 2010;107:470–6.PubMed CentralPubMedGoogle Scholar
  7. Flint AJ, Rexrode KM, Hu FB, Glynn RJ, Caspard H, Manson JE, et al. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obes Res Clin Pract. 2010;4:e171–81.View ArticlePubMed CentralPubMedGoogle Scholar
  8. Feng R-N, Zhao C, Wang C, Niu Y-C, Li K, Guo F-C, et al. BMI is strongly associated with hypertension and waist circumference is strongly associated with type 2 diabetes and dyslipidemia, in northern Chinese adults. J Epidemiol. 2012;22:317–23.View ArticlePubMed CentralPubMedGoogle Scholar
  9. Heo M, Faith MS, Pietrobelli A, Heymsfield SB. Percentage of body fat cutoffs by sex, age, and race-ethnicity in the US adult population from NHAHES 1999–2004. Am J Clin Nutr. 2012;95:594–602.View ArticlePubMedGoogle Scholar
  10. Shah NR, Braverman ER. Measuring adiposity in patients: the utility of body mass index (BMI), percent body fat, and leptin. PLOS ONE. 2012;7:e33308. doi:101371/journal.pone.0033308.View ArticlePubMed CentralPubMedGoogle Scholar
  11. Youn C-H, Bezerra HG, Wu T-H, Yang F-S, Liu C-C, Wu Y-J, et al. The normal limits, subclinical significance, related metabolic derangements and distinct biological effects of body site-specific adiposity in relatively healthy population. PLOS ONE. 2013;8:e61997. doi:101371/journal.pone.0061997.View ArticleGoogle Scholar
  12. De Larochelliěre E, Côté J, Gilbert G, Bibeau K, Ross MK, Dion-Roy V, et al. Visceral/epicardial adiposity in non-obese and apparently healthy young adults: association with the cardiometabolic profile. Athrosclerosis. 2014;234:23–9.View ArticleGoogle Scholar
  13. Nazare J-A, Smith JD, Borel A-L, Haffner SM, Baělkau B, Ross R, et al. Ethnic influences on the relations between abdominal subcutaneous and visceral adiposity, liver ft, and cardiometabolic risk profile: the international study of prediction of intra- abdominal adiposity and its relationship with cardiometabolic risk/intra-abdominal adiposity. Am J Clin Nutr. 2012;96:714–26.View ArticlePubMedGoogle Scholar
  14. Odegaard AO, Pereira MA, Koh W-P, Gross MD, Duval S, Yu MC, et al. BMI, all-cause and cause-specific mortality in Chinese Singaporean men and women: the Singapore Chinese health study. PLOS ONE. 2010;5:e14000. doi:101371/journl.pone.0014000.View ArticlePubMed CentralPubMedGoogle Scholar
  15. Kokinos P, Myers J, Faselis C, Doumas M, Kheirbek R, Nylen E. BMI-mortality paradox and fitness in African American and Caucasian men with type 2 diabetes. Diabetes Care. 2012;35:1021–7.View ArticleGoogle Scholar
  16. Chen Y, Copeland WK, Vendanthn R, Grant E, Lee JE, Gu D, et al. Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium. BMJ. 2013;347:f5446. doi:10.1136/bmj.f5446.View ArticlePubMed CentralPubMedGoogle Scholar
  17. Zaccagni L, Barbieri D, Gualdi-Russo E. Body composition and physical activity in Italian university students. J Transl Med. 2014;12:120. http://www.translational-medicine.com/content/12/1/120.View ArticlePubMed CentralPubMedGoogle Scholar
  18. Heymsfield SB, Scherzer R, Piertobelli A, Lewis CE, Grunfeld C. Body mass index as a phenotyping expression of adiposity: quantitative contribution of muscularity in a population based sample. Int J Obes. 2009;33:1363–73.View ArticleGoogle Scholar
  19. Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systemic review and meta-analysis. Obes Rev. 2012;13:275–86.View ArticlePubMedGoogle Scholar
  20. Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio and the conicity index as a screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3–19 y. Am J Clin Nutr. 2000;72:490–5.PubMedGoogle Scholar
  21. Heymsfield SB, Heo M, Pietrobelli A. Are adult body circumferences associated with height? Relevance to normative ranges and circumferential indexes. Am J Clin Nutr. 2011;93:302–7.View ArticlePubMedGoogle Scholar
  22. Lichtash CT, Ciu J, Guo X, Chen Y-DI, Hsueh WA, Rotter JI, et al. Body adiposity index versus body mass index and other anthropometric treats s correlates of cardiometabolic risk factors. PLOS ONE. 2013;8:e65954. doi:10.137/journal.pone.0065954.View ArticlePubMed CentralPubMedGoogle Scholar
  23. Krakauer NY, Krakauer JC. A new body shape index predicts mortality hazards independently of body mass index. PLoS ONE. 2012;7:e39504. doi:10.1371/journal.pone 0039504.View ArticlePubMed CentralPubMedGoogle Scholar
  24. Duncan MJ, Mota J, Vale S, Santos MP, Ribeiro JC. Associations between body mass index, waist circumference and body shape index with resting blood pressure in Portuguese adolescents. Am J Hum Biol. 2013;40:163–7.View ArticleGoogle Scholar
  25. He S, Chen X. Could the new body shape index predict the new onset of diabetes mellitus in the Chinese population? PLoS ONE. 2013;8:e50573. doi:10.1371/journal.pone. 0050573.View ArticlePubMed CentralPubMedGoogle Scholar
  26. Cheung YB. “A body shape index” in middle-age and older Indonesian population: scaling exponents and association with incident hypertension. PLoS ONE. 2014;9:e85421. doi:10.1371/journal.pone.00 85421.View ArticlePubMed CentralPubMedGoogle Scholar
  27. Haghighatdoost F, Sarrafzadegan N, Mofammadifard N, Asgary S, Botsham M, Azadbakht L. Assessing body shape index as a risk predictor for cardiovascular disease and metabolic syndrome among Iranian adults. Nutrition. 2014;30:636–44.View ArticlePubMedGoogle Scholar
  28. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163.Google Scholar
  29. Després J-P. Body fat distribution and risk of cardiovascular disease. Circulation. 2012;126:1301–13.View ArticlePubMedGoogle Scholar
  30. World Health Organization (WHO). Waist circumference and waist-to-hip ratio: Report of a WHO Expert Consultation. Geneva: WHO; 2008.Google Scholar
  31. International Diabetes Federation. Global Guideline for type 2 diabetes. www.idf.org/sites/default/files/IDF%20T2DM%20Guideline.pdf
  32. Friedewald WT, Levy R, Fredricson D. Estimation of concentrations of low density lipoprotein concentrations without use of the preparative ultra-centrifugation. Clin Chem. 1972;18:499–504.PubMedGoogle Scholar
  33. Orakzai SH, Nasir K, Blaha M, Blumenthal RS, Raggi P. Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis. 2009;202:289–95.View ArticlePubMedGoogle Scholar
  34. European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J. 2011;32:1345–61.View ArticleGoogle Scholar
  35. Perk J. European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2012;33:1635–701.View ArticlePubMedGoogle Scholar
  36. Raeven GM. Insulin resistance: the link between adiposity and cardiovascular disease. Med Clin North Am. 2011;95:875–92.View ArticleGoogle Scholar
  37. Maessen MFH, Eijsfogels TMH, Verhaggen RJHM, Hopmn MTE, Verbeek ALM, de Vegt F. Entering a new era of body indices: the feasibility of a body shape index and body roundness index to identify cardiovascular health status. PLoS One. 2014;9:e107212.View ArticlePubMed CentralPubMedGoogle Scholar
  38. Janssen I, Heymsfield SB, Allison DB, Kotler DP, Ross R. Body mass index and waist circumference independently contribute to the prediction of nonabdominal, abdominal subcutaneous, and visceral fat. Am J Clin Nutr. 2002;75:683–8.PubMedGoogle Scholar
  39. Pouliot M-C, Desprěs J-P, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sigittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol. 1994;73:460–3.View ArticlePubMedGoogle Scholar
  40. Lofgren I, Herron K, Zern T, West K, Patalay M, Shachter NS, et al. Waist circumference is a better predictor than body mass index of coronary hart disease risk in overweight premenopausal women. J Nutr. 2004;134:1071–6.PubMedGoogle Scholar
  41. Coral-Romero A, Sert-Kuniyoshi FH, Sierra-Johnston J, Orban M, Gami AQ, Davison D, et al. Modest visceral fat gain cause endothelial dysfunction in healthy humans. J Am Coll Cardiol. 2010;56:662–4.View ArticleGoogle Scholar
  42. Liu J, Fox CS, Hickson DA, May WD, Hirstone KG, Carr JJ, et al. Impact of abdominal visceral and subcutaneous adipose tissue on cardiometabolic risk factors: the Jackson Heart Study. J Clin Endocrinol Metab. 2010;95:5419–26.View ArticlePubMed CentralPubMedGoogle Scholar
  43. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Rosetti Wylie J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering. Arch Intern Med. 2008;168:1617–24.View ArticlePubMedGoogle Scholar
  44. Sucurro E, Marini MA, Frontoni S, Hibal ML, Andreozzi F, Lauro R, et al. Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals. Obesity. 2008;16:1881–6.View ArticleGoogle Scholar

Copyright

© Malara et al.; licensee BioMed Central. 2015

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Advertisement